Dr. Susan J. Hayflick, MD

Dr. Hayflick practices at OHSU Hospital in Portland, Oregon, part of State of Oregon.

Dr. Hayflick's NPI, 1538174057, was assigned on July 31, 2006. Dr. Hayflick graduated from Penn State College of Medicine in 1985. Dr. Hayflick's Oregon license number on file is MD18081.

Dr. Hayflick's primary practice is OHSU Hospital, at 3181 SW Sam Jackson Park Road, Portland, OR 97239 in Multnomah County. The practice phone is (503) 494-9000.

Dr. Hayflick's primary practice is OHSU Hospital in Portland, Oregon, part of State of Oregon. Dr. Hayflick is also affiliated with St. Charles Bend. The medical group on file is Oregon Health & Science University (OHSU). Dmand AI also links Dr. Hayflick to 3 more hospitals and 1 clinical lab, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Hayflick practices, 6 sites in all. Vendor and product names are available with a free account.

Clinical genetics (m.d.) is Dr. Hayflick's primary specialty in the NPI Registry, under taxonomy code 207SG0201X. Dr. Hayflick is board certified in clinical biochemical/molecular genetics by the American Board of Medical Genetics and Genomics. Dmand AI has Dr. Hayflick's licenses on file in 3 states: Oregon, Texas and Alaska.

CMS data shows 844 Medicare services from Dr. Hayflick across 4 procedure codes in 2024, for 475 Medicare patients. Medicare paid $25,111 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 475 Medicare patients who saw Dr. Hayflick in 2024. The largest group is 65 to 74, with 246 patients. 65% of them have high blood pressure, and 58% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.33, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Hayflick's median patient age at 54, with 52% women.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 99 out of 100 for Dr. Hayflick for performance year 2024, reported through an alternative payment model (APM). Dr. Hayflick accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 127 papers to Dr. Hayflick, published from 2004 to 2025. 2022 was the busiest year, with 6. The most frequent topics are Phosphotransferases (Alcohol Group Acceptor), Brain and Pantothenate Kinase-Associated Neurodegeneration. Dr. Hayflick has published most often in Mol Genet Metab. Dr. Hayflick's most frequent co-authors are Penelope Hogarth, MD, Michael C. Kruer, MD and Caleb Charles Rogers, MD.

Dmand AI links Dr. Hayflick to 1 clinical trial. Conditions studied include Pantothenate Kinase-Associated Neurodegeneration and Neuroaxonal Dystrophies.

CMS Open Payments shows 17 general payments to Dr. Hayflick from 3 drug and device companies from 2016 to 2018. Travel and lodging make up the largest share, 77% of the total. Apo-pharma USA, Inc. paid the most, $1,815.

Dmand AI lists 2 awards for Dr. Hayflick, most recently CMS Stage 1 EHR in 2011.

Dr. Hayflick graduated from Penn State College of Medicine in 1985.

Dr. Hayflick is in network with 20 carriers, including Aetna, Elevance and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 12. Check the plan with the practice before a visit.